Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)

Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)

מידע ביבליוגרפי
Main Authors: Shah, S, Whyte, MB, McGovern, A, Van Vlymen, JN, Hinton, W, Munro, N, de Lusignan, S
פורמט: Conference item
שפה:English
יצא לאור: Wiley 2018

פריטים דומים